Dr. Lin specializes in the treatment of gastrointestinal malignancies, particularly colorectal cancer. He is an associate professor of medicine at the…
Read Full Bio
Patient Care Philosophy
Dr. Lin offers a compassionate, individualized care plan to each person that closely involves the patient, family members and a professional care team to achieve optimal quality of life.
Dr. Lin's personal interests include spending time with his family, traveling and writing.
Dr. Lin is currently leading a National Cancer Institute-sponsored phase-III study that examines whether Celecoxib can mitigate painful swelling in the hands and feet of patients taking Capecitabine.
Dr. Lin has led nearly two dozen research protocols, as well as edited and/or written many articles and book chapters. He has two pending patent applications including one on endothelial progenitor cell marker.
He is on the editorial board of Stem Cell Translational Medicine and is a member of the American Society of Clinical Oncology and American Association for Cancer Research, among others.
In his work, Dr. Lin has observed increased complete response when combining chemotherapy and radiation for metastatic colorectal cancer. He is trying to decipher the molecular signatures, which are similar to rectal cancer.
For the past four years, Dr. Lin has been the chief architect of a book project called: "Cancer Matrix Manual," which will appear in three languages: English, Chinese and Spanish. The book will be supported by a functional website.
|USC-Keck School of Medicine||Master||1990
|Institute of Basic Medical Science||Medical education||1989
|China Medical University||Medical education||1986
|Beth Israel Deaconess Medical Center||Fellowship||
|American Board of Internal Medicine||Medical Oncology||2000